20th International Conference on Pharmaceutical Drug Design, Development and Adverse Effect

From Verify.Wiki
Jump to: navigation, search
QuickUpload1085 20170603010405.jpg


Conference Aims and Objectives

The ICPDDDAF 2018: 20th International Conference on Pharmaceutical Drug Design, Development and Adverse Effect aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmaceutical Drug Design, Development and Adverse Effect. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmaceutical Drug Design, Development and Adverse Effect.

Call for Contributions

All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Pharmaceutical Drug Design, Development and Adverse Effect are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET

Conference Proceedings

All submitted conference papers will be blind peer reviewed by three competent reviewers. The post conference proceedings will be abstracted and indexed in the International Science Index , and submitted to be indexed in the Google Scholar, Scopus and Thomson Reuters. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk. 

Special Journal Issues

ICPDDDAF 2018 has teamed up with the Special Journal Issue on Pharmaceutical Drug Design, Development and Adverse Effect. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge. 

Conference Sponsor and Exhibitor Opportunities

The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.

Important Dates

Abstracts/Full-Text Paper Submission Deadline   December 10, 2017
Notification of Acceptance/Rejection   December 31, 2017
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline   October 23, 2018
Conference Dates   November 19 - 20, 2018

Important Notes

Please ensure your submission meets WASET's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers. 

Please refer to the Paper Submission GUIDE before submitting your paper. 

Selected Conference Papers

1)21st Century Biotechnological Research and Development Advancements for Industrial Development in India
Monisha Isaac
2)Patient Support Program in Pharmacovigilance: Foster Patient Confidence and Compliance
Atul Khurana, Rajul Rastogi, Hans-Joachim Gamperl
3)Management Software for the Elaboration of an Electronic File in the Pharmaceutical Industry Following Mexican Regulations
M. Peña Aguilar Juan, Ríos Hernández Ezequiel, R. Valencia Luis 
4)Polydopamine Nanoparticle as a Stable and Capacious Nano-Reservoir of Rifampicin
Tasnuva Tamanna, Aimin Yu
5)Determinants of Profitability in Indian Pharmaceutical Firms in the New Intellectual Property Rights Regime
Shilpi Tyagi, D. K. Nauriyal
6)Quality Based Approach for Efficient Biologics Manufacturing
Takashi Kaminagayoshi, Shigeyuki Haruyama
7)Controlled Release of Glucosamine from Pluronic-Based Hydrogels for the Treatment of Osteoarthritis
Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
8)Use of Curcumin in Radiochemotherapy Induced Oral Mucositis Patients: A Control Trial Study 
Shivayogi Charantimath
9)Learners’ Violent Behaviour and Drug Abuse as Major Causes of Tobephobia in Schools
Prakash Singh
10)The Effect of a Three-Month Training Program on the Back Kyphosis of Former Male Addicts
M. J. Pourvaghar, Sh. Khoshemehry
11)Speciation, Preconcentration, and Determination of Iron(II) and (III) Using 1,10-Phenanthroline Immobilized on Alumina-Coated Magnetite Nanoparticles as a Solid Phase Extraction Sorbent in Pharmaceutical Products
Hossein Tavallali, Mohammad Ali Karimi, Gohar Deilamy-Rad
12)Treatment of Mycotic Dermatitis in Domestic Animals with Poly Herbal Drug
U. Umadevi, T. Umakanthan
13)Radiochemical Purity of 68Ga-BCA-Peptides: Separation of All 68Ga Species with a Single iTLC Strip
Anton A. Larenkov, Alesya Ya Maruk
14)Identifying a Drug Addict Person Using Artificial Neural Networks
Mustafa Al Sukar, Azzam Sleit, Abdullatif Abu-Dalhoum, Bassam Al-Kasasbeh
15)Co-payment Strategies for Chronic Medications: A Qualitative and Comparative Analysis at European Level
Pedro M. Abreu, Bruno R. Mendes

References

https://www.waset.org/conference/2018/11/havana/ICPDDDAF

Verification history